These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 6275676

  • 1. Effects on arterial receptors of ergot derivatives used in migraine.
    Müller-Schweinitzer E, Fanchamps A.
    Adv Neurol; 1982; 33():343-56. PubMed ID: 6275676
    [No Abstract] [Full Text] [Related]

  • 2. Agonists and antagonists of 5-hydroxytryptamine on venomotor receptors.
    Aellig WH.
    Adv Neurol; 1982; 33():321-4. PubMed ID: 7055012
    [No Abstract] [Full Text] [Related]

  • 3. Some aspects of the dopaminergic action of ergot derivatives and their role in the treatment of migraine.
    Horowski R.
    Adv Neurol; 1982; 33():325-34. PubMed ID: 7055013
    [No Abstract] [Full Text] [Related]

  • 4. Tryptaminergic receptors in the bovine pulmonary vasculature: effects of ketanserin.
    Ogunbiyi PO, Eyre P.
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):31-55. PubMed ID: 6328601
    [Abstract] [Full Text] [Related]

  • 5. Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels. Possible implications in migraine.
    Hardebo JE, Edvinsson L, Owman C, Svendgaard NA.
    Neurology; 1978 Jan; 28(1):64-70. PubMed ID: 563539
    [Abstract] [Full Text] [Related]

  • 6. Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta.
    Apperley E, Humphrey PP, Levy GP.
    Br J Pharmacol; 1976 Oct; 58(2):211-21. PubMed ID: 184872
    [Abstract] [Full Text] [Related]

  • 7. Agonists and antagonists of vascular receptors.
    Saxena PR.
    Adv Neurol; 1982 Oct; 33():309-14. PubMed ID: 7034489
    [No Abstract] [Full Text] [Related]

  • 8. [Serotonin agonists and antagonists in migraine].
    Ollat H.
    Pathol Biol (Paris); 1992 Apr; 40(4):389-96. PubMed ID: 1353874
    [Abstract] [Full Text] [Related]

  • 9. [Classification, pathogenesis and drug therapy of migraine and related forms of headache].
    Fanchamps A.
    Med Welt; 1975 Aug 29; 6(35):1518-23. PubMed ID: 241000
    [No Abstract] [Full Text] [Related]

  • 10. Evidence for stimulation of 5-HT receptors in canine saphenous arteries by ergotamine.
    Müller-Schweinitzer E.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct 29; 295(1):41-4. PubMed ID: 1004641
    [Abstract] [Full Text] [Related]

  • 11. Studies on the 5-HT receptor in vascular smooth muscle.
    Müller-Schweinitzer E.
    Res Clin Stud Headache; 1978 Oct 29; 6():6-12. PubMed ID: 725257
    [Abstract] [Full Text] [Related]

  • 12. [Experimental pharmacological studies of the venous tonus-modifying effect of dihydroergotamine].
    Glusa E.
    Z Gesamte Inn Med; 1984 Sep 01; 39(17):414-7. PubMed ID: 6095548
    [Abstract] [Full Text] [Related]

  • 13. Change in serotonin and catecholamines vascular reactivity during migraine attack.
    Franchi G, Anselmi B, Michelacci S.
    Res Clin Stud Headache; 1970 Sep 01; 3():304-9. PubMed ID: 5527211
    [No Abstract] [Full Text] [Related]

  • 14. Response of dog's femoral artery strips to vasoactive substances.
    Gerová M, Blasková I, Dolezel S.
    Physiol Bohemoslov; 1970 Sep 01; 19(3):217-21. PubMed ID: 4395622
    [No Abstract] [Full Text] [Related]

  • 15. The animal pharmacology of drugs used in the treatment of migraine.
    Fozard JR.
    J Pharm Pharmacol; 1975 May 01; 27(5):297-321. PubMed ID: 239131
    [No Abstract] [Full Text] [Related]

  • 16. Antihypertensive properties of ketanserin (R 41 468).
    Vanhoutte PM, Van Nueten JM, Symoens J, Janssen PA.
    Fed Proc; 1983 Feb 01; 42(2):182-5. PubMed ID: 6295821
    [Abstract] [Full Text] [Related]

  • 17. The effects of humoral agents and antimigraine drugs on the cranial circulation of the monkey.
    Spira PJ, Mylecharane EJ, Lance JW.
    Res Clin Stud Headache; 1976 Feb 01; 4():37-75. PubMed ID: 818690
    [No Abstract] [Full Text] [Related]

  • 18. Biochemical pharmacological profile of migraine prophylactics of pizotifen type.
    Dlohozková N, Metys J, Valchár M, Soucek R.
    Act Nerv Super (Praha); 1989 Dec 01; 31(4):300-1. PubMed ID: 2638122
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Drug treatment of migraine attacks. Pharmacological considerations].
    Salvesen R.
    Tidsskr Nor Laegeforen; 1996 Aug 10; 116(18):2176-9. PubMed ID: 8801661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.